
Results
17
Financially healthy companies listed on Asian stock exchanges with an impressive track record.
17 companies
Laurus Labs
Market Cap: ₹979.3b
Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.
LAURUSLABS
₹1,814.00
7D
-2.4%
1Y
105.2%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$62.1b
A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.
2315
HK$63.20
7D
-6.1%
1Y
179.9%
Anthem Biosciences
Market Cap: ₹501.8b
Operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally.
ANTHEM
₹891.05
7D
-0.07%
1Y
8.9%
Emcure Pharmaceuticals
Market Cap: ₹355.4b
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.
EMCURE
₹1,874.50
7D
-6.2%
1Y
27.5%
Sai Life Sciences
Market Cap: ₹305.5b
Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally.
SAILIFE
₹1,440.10
7D
-0.3%
1Y
58.1%
Neuland Laboratories
Market Cap: ₹299.2b
Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.
524558
₹23,319.85
7D
1.6%
1Y
78.8%
Rubicon Research
Market Cap: ₹298.6b
Operates as a specialty pharmaceutical company in India, the United States, and internationally.
RUBICON
₹1,804.10
7D
9.0%
1Y
n/a
Acutaas Chemicals
Market Cap: ₹277.7b
Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.
ACUTAAS
₹3,391.40
7D
4.5%
1Y
142.9%
Aether Industries
Market Cap: ₹216.8b
Produces and sells advanced intermediates and specialty chemicals in India and internationally.
AETHER
₹1,633.60
7D
-0.04%
1Y
113.4%
Granules India
Market Cap: ₹210.9b
Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), finished dosages (FDs), and peptides CDMO in India and internationally.
532482
₹851.10
7D
-1.1%
1Y
86.3%
Inner Mongolia Furui Medical Science
Market Cap: CN¥11.6b
Inner Mongolia Furui Medical Science Co., Ltd.
300049
CN¥43.91
7D
-2.2%
1Y
-39.2%
Shilpa Medicare
Market Cap: ₹158.4b
Offers pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation (CDMO) services in India, the United States, Europe, and internationally.
530549
₹810.10
7D
-1.1%
1Y
86.7%
Viyash Scientific
Market Cap: ₹111.1b
Operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally.
512529
₹254.65
7D
-2.6%
1Y
44.3%
Strides Pharma Science
Market Cap: ₹87.5b
A pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally.
STAR
₹949.10
7D
-5.4%
1Y
9.2%
IOL Chemicals and Pharmaceuticals
Market Cap: ₹46.9b
Manufactures and sells pharmaceutical and chemical products in India and internationally.
524164
₹159.65
7D
-2.4%
1Y
64.2%
Sakar Healthcare
Market Cap: ₹19.9b
Research, develops, manufactures, and sells pharmaceutical products in India.
SAKAR
₹893.70
7D
-6.3%
1Y
181.8%
Hyphens Pharma International
Market Cap: S$112.8m
Operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally.
1J5
S$0.36
7D
-2.7%
1Y
23.7%